These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 2149204)

  • 41. Purpura fulminans in neonates and childhood.
    Takayanagi K; Grochwska E; Al-Bader M; Doresowamy N; Freeman NV
    Z Kinderchir; 1985 Jun; 40(3):182-7. PubMed ID: 4036371
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Idiopathic purpura fulminans with transient protein S deficiency].
    de Frutos Martínez C; Iturrioz Mata A; González Pérez-Yarza E; Arratibel Fuentes MC; Sainz Arroniz R; Albisu Andrade Y
    An Esp Pediatr; 2001 Oct; 55(4):369-73. PubMed ID: 11578547
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Novel Protein C Mutation Causing Neonatal Purpura Fulminans.
    Devi R U; Bharathi S M; Kawankar N
    Indian Pediatr; 2016 Nov; 53(11):1019-1021. PubMed ID: 27889735
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Purpura fulminans. A cutaneous manifestation of severe protein C deficiency.
    Auletta MJ; Headington JT
    Arch Dermatol; 1988 Sep; 124(9):1387-91. PubMed ID: 3415283
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Homozygous protein C deficiency presenting as neonatal purpura fulminans: management with fresh frozen plasma, low molecular weight heparin and protein C concentrate.
    Kizilocak H; Ozdemir N; Dikme G; Koc B; Celkan T
    J Thromb Thrombolysis; 2018 Feb; 45(2):315-318. PubMed ID: 29270858
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Empiric treatment of protracted idiopathic purpura fulminans in an infant: a case report and review of the literature.
    Macheret F; Pundi KN; Broomall EM; Davis DM; Rodriguez V; Brands CK
    J Med Case Rep; 2011 May; 5():201. PubMed ID: 21605440
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Postinfection purpura fulminans in a patient heterozygous for prothrombin G20210A and acquired protein S resistance.
    al-Ismail S; Collins P; Najib R; James-Ellison M; O'Hagan M
    Pediatr Hematol Oncol; 1999; 16(6):561-4. PubMed ID: 10599098
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Negative pressure dressing for promoting wound healing of purpura fulminans in a newborn with homozygous protein C deficiency.
    Chuansumrit A; Kanogsunthornrat N; Sirachainan N; Porapakpenjun S; Chantarukha R; Warrasak S; Wongwerawattanakoon P
    Blood Coagul Fibrinolysis; 2007 Jan; 18(1):77-9. PubMed ID: 17179832
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A case of purpura fulminans is caused by homozygous delta8857 mutation (protein C-nagoya) and successfully treated with activated protein C concentrate.
    Nakayama T; Matsushita T; Hidano H; Suzuki C; Hamaguchi M; Kojima T; Saito H
    Br J Haematol; 2000 Sep; 110(3):727-30. PubMed ID: 10997987
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Postvaricella purpura fulminans with no evidence of disseminated intravascular coagulation (DIC) or protein S deficiency.
    Sharma VK; Dubey TN; Dave L; Agarwal A
    J Indian Med Assoc; 2010 Aug; 108(8):529-30. PubMed ID: 21404754
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel mutation in protein C gene (PROC) causing severe phenotype in neonatal period.
    Unal S; Gumruk F; Yigit S; Tuncer M; Tavil B; Cil O; Takci S; Urata M; Hotta T; Kang D; Cetin M
    Pediatr Blood Cancer; 2014 Apr; 61(4):763-4. PubMed ID: 24115609
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Management of neonatal purpura fulminans with severe protein C deficiency.
    Sen K; Roy A
    Indian Pediatr; 2006 Jun; 43(6):542-5. PubMed ID: 16820665
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Atypical purpura fulminans with benign monoclonal gammopathy.
    Friedenberg WR; West M; Miech DJ; Mazza JJ
    Arch Dermatol; 1978 Apr; 114(4):578-80. PubMed ID: 646371
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acquired purpura fulminans induced by alcohol and acetaminophen. Successful treatment with heparin and vitamin K.
    Guccione JL; Zemtsov A; Cobos E; Neldner KH
    Arch Dermatol; 1993 Oct; 129(10):1267-9. PubMed ID: 8215490
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Modern concepts of the diagnosis and treatment of purpura fulminans.
    Edlich RF; Cross CL; Dahlstrom JJ; Long WB
    J Environ Pathol Toxicol Oncol; 2008; 27(3):191-6. PubMed ID: 18652566
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The frequency of type I heterozygous protein S and protein C deficiency in 141 unrelated young patients with venous thrombosis.
    Gladson CL; Scharrer I; Hach V; Beck KH; Griffin JH
    Thromb Haemost; 1988 Feb; 59(1):18-22. PubMed ID: 2966450
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Purpura fulminans associated with varicella and polyvalent protective inoculations (author's transl)].
    Stopfkuchen H; Jüngst BK; Wilutzky H
    Klin Padiatr; 1976 Mar; 188(2):190-3. PubMed ID: 944357
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Protein C (PROC) gene mutations in two Indian families with purpura fulminans.
    Pai N; Shetty S; Ghosh K
    Ann Hematol; 2010 Aug; 89(8):835-6. PubMed ID: 20077116
    [No Abstract]   [Full Text] [Related]  

  • 59. Severe protein S deficiency associated with heterozygous factor V Leiden mutation in a child with purpura fulminans.
    Dogan Y; Aygun D; Yilmaz Y; Kanra G; Secmeer G; Besbas N; Gurgey A
    Pediatr Hematol Oncol; 2003; 20(1):1-5. PubMed ID: 12687747
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of protein C concentrate in neonatal period.
    De Carolis MP
    Minerva Pediatr; 2010 Jun; 62(3 Suppl 1):29-30. PubMed ID: 21089715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.